Published in J Neuroimmunol on August 01, 2002
Reversible demyelination, blood-brain barrier breakdown, and pronounced neutrophil recruitment induced by chronic IL-1 expression in the brain. Am J Pathol (2004) 1.31
Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1beta in human monocytes and multiple sclerosis. Proc Natl Acad Sci U S A (2009) 1.31
The diminishment of experimental autoimmune encephalomyelitis (EAE) by neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH) therapy. Brain Behav Immun (2008) 0.98
Interleukin-1beta upregulates functional expression of neurokinin-1 receptor (NK-1R) via NF-kappaB in astrocytes. Glia (2004) 0.97
A Multiplex Protein Panel Applied to Cerebrospinal Fluid Reveals Three New Biomarker Candidates in ALS but None in Neuropathic Pain Patients. PLoS One (2016) 0.82
Magnetic resonance imaging reveals therapeutic effects of interferon-beta on cytokine-induced reactivation of rat model of multiple sclerosis. J Cereb Blood Flow Metab (2013) 0.78
Association of IL-1beta, IL-1ra, and TNF-alpha gene polymorphisms in childhood nephrotic syndrome. Pediatr Nephrol (2004) 0.78
Interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms in Greek multiple sclerosis (MS) patients with bout-onset MS. Neurol Sci (2009) 0.77
Interleukin (IL)-1 gene polymorphisms: relevance of disease severity associated alleles with IL-1beta and IL-1ra production in multiple sclerosis. Mediators Inflamm (2003) 0.76
Cytokine gene polymorphism in idiopathic nephrotic syndrome children. Indian J Clin Biochem (2011) 0.76
Association study of functional genetic variants of innate immunity related genes in celiac disease. BMC Med Genet (2005) 0.76
Sphingosine-1-phosphate inhibits IL-1-induced expression of C-C motif ligand 5 via c-Fos-dependent suppression of IFN-β amplification loop. FASEB J (2015) 0.75
Association of interleukin-1 gene polymorphisms with multiple sclerosis: a meta-analysis. Inflamm Res (2012) 0.75
Analysing the effect of candidate genes on complex traits: an application in multiple sclerosis. Immunogenetics (2006) 0.75
Automated microbiological detection/identification system. J Clin Microbiol (1977) 16.88
Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging. Nat Neurosci (2003) 10.44
Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax (1999) 8.63
Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J (2008) 5.38
A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J (2002) 4.68
Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12). Neurology (2003) 3.75
Oxpentifylline treatment of venous ulcers of the leg. BMJ (1990) 3.75
Neural correlates of motor recovery after stroke: a longitudinal fMRI study. Brain (2003) 3.65
Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax (2003) 3.62
Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax (2009) 3.54
Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev (2001) 3.43
Statistical analysis of exacerbation rates in COPD: TRISTAN and ISOLDE revisited. Eur Respir J (2008) 3.36
Sunshine is good medicine. The health benefits of ultraviolet-B induced vitamin D production. J Cosmet Dermatol (2003) 3.33
Neural correlates of outcome after stroke: a cross-sectional fMRI study. Brain (2003) 3.04
Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology (2000) 3.01
Impact of preventing exacerbations on deterioration of health status in COPD. Eur Respir J (2004) 2.80
Glutathione-S-transferase family of enzymes. Mutat Res (2001) 2.74
Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain (2008) 2.67
Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol (1999) 2.61
Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis. Neurology (1999) 2.54
Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain (1996) 2.54
Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. Brain (1990) 2.53
Health status deterioration in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 2.52
Progressive cerebral atrophy in MS: a serial study using registered, volumetric MRI. Neurology (2000) 2.47
Performance, ventilation, and oxygen consumption in three different types of exercise test in patients with chronic obstructive lung disease. Thorax (1985) 2.47
Diffusion tensor imaging can detect and quantify corticospinal tract degeneration after stroke. J Neurol Neurosurg Psychiatry (2000) 2.44
Susceptibility to melanoma: influence of skin type and polymorphism in the melanocyte stimulating hormone receptor gene. J Invest Dermatol (1998) 2.37
Mutation of invH, but not stn, reduces Salmonella-induced enteritis in cattle. Infect Immun (1998) 2.29
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm. J Viral Hepat (2014) 2.23
Cognitive function in COPD. Eur Respir J (2010) 2.22
Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD. Am J Respir Crit Care Med (1995) 2.20
Examination of slurry from cattle for pathogenic bacteria. J Hyg (Lond) (1975) 2.13
Prednisolone response in patients with chronic obstructive pulmonary disease: results from the ISOLDE study. Thorax (2003) 2.11
Time course of recovery of health status following an infective exacerbation of chronic bronchitis. Thorax (2003) 2.11
Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results. Eur Respir J (2009) 2.11
Basal cell carcinoma. BMJ (2003) 2.10
Biodiversity of stream insects: variation at local, basin, and regional scales. Annu Rev Entomol (1998) 2.10
Traumatic Rupture of the Choledochus, Associated with an Acute Hemorrhagic Pancreatitis and a Bile Peritonitis. Ann Surg (1948) 2.10
Evidence for related virulence sequences in plasmids of Salmonella dublin and Salmonella typhimurium. J Gen Microbiol (1985) 2.07
A comparison of the visual analogue scale and modified Borg scale for the measurement of dyspnoea during exercise. Clin Sci (Lond) (1989) 2.06
Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. J Neurol Neurosurg Psychiatry (1991) 2.05
Do routine antibiotics after loop diathermy excision reduce morbidity? Br J Obstet Gynaecol (1998) 2.05
The Functional Independence Measure: a comparative validity and reliability study. Disabil Rehabil (1995) 2.04
Primary and revision lumbar discectomy. A 16-year review from one centre. J Bone Joint Surg Br (2003) 2.03
Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am J Epidemiol (2006) 2.02
Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry (1996) 2.02
Initial metabolic and hormonal response to acute myocardial infarction. Lancet (1974) 2.02
Clinical appropriateness: a key factor in outcome measure selection: the 36 item short form health survey in multiple sclerosis. J Neurol Neurosurg Psychiatry (2000) 2.01
Brain atrophy in clinically early relapsing-remitting multiple sclerosis. Brain (2002) 2.01
Validation of the St. George's Respiratory Questionnaire in bronchiectasis. Am J Respir Crit Care Med (1997) 2.01
Immunologic studies in IgA nephropathy. Kidney Int (1980) 1.99
The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. Brain (1998) 1.99
Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review. Lancet (2000) 1.98
Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up. J Neurol Neurosurg Psychiatry (2005) 1.97
Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax (2006) 1.96
American translation, modification, and validation of the St. George's Respiratory Questionnaire. Clin Ther (2000) 1.90
Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology (1993) 1.87
Comparative Responses of Globodera rostochiensis and G. pallida to Hatching Chemicals. J Nematol (2001) 1.87
The human glutathione S-transferases: studies on the tissue distribution and genetic variation of the GST1, GST2 and GST3 isozymes. Ann Hum Genet (1984) 1.85
The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group. Neurology (1999) 1.82
The Salmonella dublin virulence plasmid mediates systemic but not enteric phases of salmonellosis in cattle. Infect Immun (1995) 1.81
Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis. Neurology (2008) 1.80
A randomised controlled trial of epidural compared with non-epidural analgesia in labour. BJOG (2001) 1.79
Characterization of intestinal invasion by Salmonella typhimurium and Salmonella dublin and effect of a mutation in the invH gene. Infect Immun (1995) 1.75
Identification of SopE2, a Salmonella secreted protein which is highly homologous to SopE and involved in bacterial invasion of epithelial cells. J Bacteriol (2000) 1.74
The impact of inpatient rehabilitation on progressive multiple sclerosis. Ann Neurol (1997) 1.73
Current perspectives in salmonellosis. Br Vet J (1995) 1.72
Identification of two lithocholic acid-binding proteins. Separation of ligandin from glutathione S-transferase B. Biochem J (1979) 1.71
Mortality in rheumatoid arthritis: relationship to single and composite measures of disease activity. Rheumatology (Oxford) (2001) 1.70
Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. Brain (1996) 1.69
Quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia. Thorax (1996) 1.69
Community services in multiple sclerosis: still a matter of chance. J Neurol Neurosurg Psychiatry (2000) 1.68
Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain (1994) 1.68
Historical epidemiology of hepatitis C virus (HCV) in selected countries. J Viral Hepat (2014) 1.68
The dose-response characteristics of inhaled corticosteroids when used to treat asthma: an overview of Cochrane systematic reviews. Respir Med (2006) 1.67
Do patients with rheumatoid arthritis established on methotrexate and folic acid 5 mg daily need to continue folic acid supplements long term? Rheumatology (Oxford) (2000) 1.67
Strategies to manage hepatitis C virus (HCV) disease burden. J Viral Hepat (2014) 1.67
Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol (2000) 1.66
Evidence-based measurement: which disability scale for neurologic rehabilitation? Neurology (2001) 1.66
Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature. J Clin Endocrinol Metab (2010) 1.65
Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples. J Neurol Neurosurg Psychiatry (2002) 1.64
Responsiveness and predictive value of EDSS and MSFC in primary progressive MS. Neurology (2008) 1.62
Effects of intravenous methylprednisolone on outcome in MRI-based prognostic subgroups in acute optic neuritis. Neurology (1998) 1.62
Polymorphism at the glutathione S-transferase GSTP1 locus. A new marker for bronchial hyperresponsiveness and asthma. Am J Respir Crit Care Med (2000) 1.61
The glutathione S-transferases: influence of polymorphism on cancer susceptibility. IARC Sci Publ (1999) 1.60
Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial. Neurology (1997) 1.60
Glutathione S-transferase: genetics and role in toxicology. Toxicol Lett (2000) 1.59
A novel, short, and simple questionnaire to measure health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 1.59
Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry (2005) 1.59
Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations. Neurology (2001) 1.58
Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination. Neurology (1999) 1.58
Fatigue is not associated with raised inflammatory markers in multiple sclerosis. Neurology (2001) 1.58
Spinal cord repair in MS: does mitochondrial metabolism play a role? Neurology (2010) 1.56